Waters Corporation (WAT) has experienced market movements indicative of a complex financial journey. The company's stock units were granted to
Director Heather Knight and
Wei Jiang while other entities like
Mackenzie Financial Corp and
SG Americas Securities LLC have also acquired significant shares in the company. Waters Corp underwent a massive
$3.5 billion senior notes offering and successfully completed the
combination with BD's Biosciences & Diagnostic Solutions Business. However, the newly acquired BD business arrived softer than expected, causing a temporary drop in Waters' stock. Despite this, Waters ended Q4 with results mostly in line with expectations. In some good news, the company saw
strong revenue growth and had to revise its guidance upwards in 2025 earnings calls. Perhaps owed to these developments,
Goldman Sachs reinstated a buy rating on Waters Corp stock, and the company saw a price uptick. However, despite a Q4 beat, Waters' stock slipped on their outlook and fell short of profit forecasts for Q1. Critically,
Director Jiang Wei purchased $144k in Waters' shares indicating potential insider confidence. Yet, some still call for selling Waters' shares, citing various reasons.
Waters Corp WAT News Analytics from Mon, 14 Jul 2025 07:00:00 GMT to Sat, 04 Apr 2026 15:11:56 GMT -
Rating 1
- Innovation 2
- Information 6
- Rumor -2
